Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Hepatocellular Carcinoma Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00428220
What this trial is testing

A Continuation Study Using Sunitinib Malate For Patients Leaving Treatment On A Previous Sunitinib Study.

Who this might be right for
Metastatic Breast CancerAdvanced Breast CancerMetastatic Castration Resistant Prostate Cancer+9 more
Pfizer 223
Early research (Phase 1)Study completedNCT00654160
What this trial is testing

Irinotecan, Fluorouracil, and Leucovorin in Treating Patients With Advanced Gastrointestinal Cancer

Who this might be right for
Anal CancerCarcinoma of the AppendixColorectal Cancer+9 more
Mayo Clinic 7
Not applicableUnknownNCT04521491
What this trial is testing

A Trial of Adjuvant Therapy After Hepatocarcinoma Resection Based on Folate Receptor-positive Circulating Tumor Cells

Who this might be right for
Hepatocellular Carcinoma
Eastern Hepatobiliary Surgery Hospital 184
Early research (Phase 1)Study completedNCT02870010
What this trial is testing

Chemoembolization of Non-resectable Non-metastatic Hepatocellular Carcinoma Using Embolization Microspheres

Who this might be right for
Localized Non-Resectable Adult Hepatocellular Carcinoma
Centre Hospitalier Universitaire Dijon 21
Testing effectiveness (Phase 2)Study completedNCT04696055
What this trial is testing

Regorafenib Plus Pembrolizumab in Patients With Advanced or Spreading Liver Cancer Who Have Been Previously Treated With PD-1/PD-L1 Immune Checkpoint Inhibitors

Who this might be right for
Hepatocellular Carcinoma
Bayer 95
Testing effectiveness (Phase 2)Looking for participantsNCT06811116
What this trial is testing

Testing the Addition of an Anti-cancer Drug, Sapanisertib, to the Usual Chemotherapy Treatment (Cabozantinib) in Metastatic Liver Cell Cancer With a Change in Genes for the Protein β-Catenin, The SAPHIRE Trial

Who this might be right for
Advanced Hepatocellular CarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8+1 more
National Cancer Institute (NCI) 92
Large-scale testing (Phase 3)Study completedNCT03434379
What this trial is testing

Atezolizumab in Combination With Bevacizumab Compared With Sorafenib in Patients With Untreated Locally Advanced or Metastatic Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Hoffmann-La Roche 558
Not applicableUnknownNCT00797251
What this trial is testing

Anatomical Right Posterior Sectionectomy of the Liver by IOUS-Guided Finger Compression

Who this might be right for
Colorectal Liver MetastasesHepatocellular CarcinomaLiver Malignancies
University of Milan 10
Early research (Phase 1)WithdrawnNCT03217253
What this trial is testing

Tazemetostat in Treating Patients With Metastatic or Unresectable Solid Tumors or B-Cell Lymphomas With Liver Dysfunction

Who this might be right for
Ann Arbor Stage III B-Cell Non-Hodgkin LymphomaAnn Arbor Stage IV B-Cell Non-Hodgkin LymphomaMetastatic Malignant Solid Neoplasm+8 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07495579
What this trial is testing

Lenvatinib or Regorafenib for Advanced Hepatocellular Carcinoma After Immunotherapy (REVIVE)

Who this might be right for
Hepatocellular Carcinoma (HCC)
Asan Medical Center 146
Early research (Phase 1)Study completedNCT00005842
What this trial is testing

Trastuzumab Plus R115777 in Treating Patients With Advanced or Metastatic Cancer

Who this might be right for
Cancer
National Cancer Institute (NCI) 24
Testing effectiveness (Phase 2)Ended earlyNCT03026803
What this trial is testing

Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer

Who this might be right for
Liver CancerHepatocellular Cancer
City of Hope Medical Center 4
Not applicableStudy completedNCT01720706
What this trial is testing

Thermal Ablation in Larger Liver and Kidney Tumours

Who this might be right for
Liver and Kidney Tumours
University Health Network, Toronto 12
Large-scale testing (Phase 3)Not Yet RecruitingNCT06680258
What this trial is testing

TPST-1120 With Atezolizumab Plus Bevacizumab in Patients With Unresectable or Metastatic HCC Not Previously Treated With Systemic Therapy

Who this might be right for
Hepatocellular Carcinoma (HCC)
Tempest Therapeutics 740
Not applicableStudy completedNCT02973204
What this trial is testing

Circulating Tumor Cells and Tumor DNA in HCC and NET

Who this might be right for
Carcinoma, HepatocellularNeuroendocrine Tumors
University of Aarhus 167
Testing effectiveness (Phase 2)Ended earlyNCT04785287
What this trial is testing

Anti-CTLA4-NF mAb (BMS986218), Nivolumab, and Stereotactic Body Radiation Therapy for the Treatment of Metastatic Solid Malignancies

Who this might be right for
Advanced Lung CarcinomaAdvanced Malignant Solid NeoplasmMalignant Adrenal Gland Neoplasm+14 more
M.D. Anderson Cancer Center 13
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07684040
What this trial is testing

Combination Therapy in Patients With Resectable Liver Cancer

Who this might be right for
Liver Cancer (Primary and Metastatic)
Affiliated Hospital of Guangdong Medical University 68
Not applicableUnknownNCT04708483
What this trial is testing

DCE-CT of Thoracic Tumors as an Early Biomarker for Treatment Monitoring in Comparison With Morphologic Criteria

Who this might be right for
Cancer, LungPerfusion Computed Tomography Target LesionCancer Liver+2 more
Hyperfusion 100
Early research (Phase 1)Looking for participantsNCT06687941
What this trial is testing

Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors

Who this might be right for
NeoplasmsCarcinoma, HepatocellularCarcinoma, Non-Small-Cell Lung+1 more
Aptamer Sciences, Inc. 70
Testing effectiveness (Phase 2)WithdrawnNCT01859182
What this trial is testing

Selumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duct Cancer That Cannot Be Removed By Surgery

Who this might be right for
Adenocarcinoma of the GallbladderAdenocarcinoma With Squamous Metaplasia of the GallbladderAdult Primary Cholangiocellular Carcinoma+12 more
National Cancer Institute (NCI)
Next Page